TY - JOUR
T1 - Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis
AU - Greenlee-Wacker, Mallary C.
AU - Briseño, Carlos
AU - Galvan, Manuel
AU - Moriel, Gabriela
AU - Velázquez, Peter
AU - Bohlson, Suzanne S.
PY - 2011/9/15
Y1 - 2011/9/15
N2 - CD93 is emerging as a novel regulator of inflammation; however, its molecular function is unknown. CD93 exists as a membraneassociated glycoprotein on the surface of cells involved in the inflammatory cascade, including endothelial and myeloid cells. A soluble form (sCD93) is detectable in blood and is elevated with inflammation. In this study, we demonstrate heightened susceptibility to thioglycollate-induced peritonitis in CD93-/- mice. CD93-/- mice showed a 1.6-1.8-fold increase in leukocyte infiltration during thioglycollate-induced peritonitis between 3 and 24 h that returned to wild type levels by 96 h. Impaired vascular integrity in CD93 -/- mice during peritonitis was demonstrated using fluorescence multiphoton intravital microscopy; however, no differences in cytokine or chemokine levels were detected with Luminex Multiplex or ELISA analysis. C1q-hemolytic activity in CD93-/-mice was decreased by 22% at time zero and by 46% 3 h after thioglycollate injection, suggesting a defect in the classical complement pathway. Leukocyte recruitment and C1q-hemolytic activity was restored to wild type levels when CD93 was expressed on either hematopoietic cells or nonhematopoietic cells in bone marrow chimeric mice. However, elevated levels of sCD93 in inflammatory fluid were observed only when CD93 was expressed on nonhematopoietic cells. Because cell-associated CD93 was sufficient to restore a normal inflammatory response, these data suggest that cell-associated CD93, and not sCD93, regulates leukocyte recruitment and complement activation during murine peritonitis.
AB - CD93 is emerging as a novel regulator of inflammation; however, its molecular function is unknown. CD93 exists as a membraneassociated glycoprotein on the surface of cells involved in the inflammatory cascade, including endothelial and myeloid cells. A soluble form (sCD93) is detectable in blood and is elevated with inflammation. In this study, we demonstrate heightened susceptibility to thioglycollate-induced peritonitis in CD93-/- mice. CD93-/- mice showed a 1.6-1.8-fold increase in leukocyte infiltration during thioglycollate-induced peritonitis between 3 and 24 h that returned to wild type levels by 96 h. Impaired vascular integrity in CD93 -/- mice during peritonitis was demonstrated using fluorescence multiphoton intravital microscopy; however, no differences in cytokine or chemokine levels were detected with Luminex Multiplex or ELISA analysis. C1q-hemolytic activity in CD93-/-mice was decreased by 22% at time zero and by 46% 3 h after thioglycollate injection, suggesting a defect in the classical complement pathway. Leukocyte recruitment and C1q-hemolytic activity was restored to wild type levels when CD93 was expressed on either hematopoietic cells or nonhematopoietic cells in bone marrow chimeric mice. However, elevated levels of sCD93 in inflammatory fluid were observed only when CD93 was expressed on nonhematopoietic cells. Because cell-associated CD93 was sufficient to restore a normal inflammatory response, these data suggest that cell-associated CD93, and not sCD93, regulates leukocyte recruitment and complement activation during murine peritonitis.
UR - http://www.scopus.com/inward/record.url?scp=80053087267&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1100803
DO - 10.4049/jimmunol.1100803
M3 - Article
C2 - 21849679
AN - SCOPUS:80053087267
VL - 187
SP - 3353
EP - 3361
JO - Journal of Immunology
JF - Journal of Immunology
SN - 0022-1767
IS - 6
ER -